Laronidase Intravenous and Pneumococcal Conjugate Vaccine (13-Valent)
Determining the interaction of Laronidase Intravenous and Pneumococcal Conjugate Vaccine (13-Valent) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: laronidase
Brand name: Aldurazyme
Synonyms: Laronidase
Generic Name: pneumococcal 13-valent vaccine
Brand name: Prevnar 13
Synonyms: Pneumococcal 13-valent conjugate vaccine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Laronidase Intravenous-Pneumococcal Conjugate Vaccine (7-Valent)
- Laronidase Intravenous-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Laronidase Intravenous-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Laronidase Intravenous-Pneumovax 23
- Laronidase Intravenous-PNV - Omega
- Laronidase Intravenous-PNV Iron Polysaccharides, Folic Acid, DHA
- Pneumococcal Conjugate Vaccine (13-Valent)-Larotrectinib
- Pneumococcal Conjugate Vaccine (13-Valent)-Larotrectinib Capsules
- Pneumococcal Conjugate Vaccine (13-Valent)-Larotrectinib Oral Solution
- Pneumococcal Conjugate Vaccine (13-Valent)-Larotrectinib Sulfate
- Pneumococcal Conjugate Vaccine (13-Valent)-Lartruvo
- Pneumococcal Conjugate Vaccine (13-Valent)-Larynex